Brands Eyeing Chinese Expats in Singapore to Fuel Sales Post-COVID-19

4 years ago

As retail sales steadily recover, Chinese Expats have renewed their strong shopping sentiment with 63% spending more post COVID-19: EternityX…

4 years ago

Canada�s Derivatives Exchange further expands global reach, syncing trading hours with Asia Pacific markets in support of growing investor demand…

4 years ago

PETALING JAYA, Malaysia--(BUSINESS WIRE)--#AllianceIslamicBank--Artificial Intelligence and Big Data technology market leader Fusionex recently signed an MoU with Alliance Islamic Bank…

Rio Tinto to triple Weipa solar capacity and add battery storage to help power operations

4 years ago

MELBOURNE, Australia--(BUSINESS WIRE)--Rio Tinto has approved a new solar farm and battery storage at Weipa in Queensland, in a move…

Datopotamab Deruxtecan Shows Encouraging Tumor Response in Patients with Advanced Non-Small Cell Lung Cancer with Actionable Genomic Alterations

4 years ago

Sub-analysis of TROPION-PanTumor01 phase 1 trial of datopotamab deruxtecan featured as late-breaking Mini Oral presentation at ESMO TROPION-Lung05 phase 2…

4 years ago

�The approval marks the first time a monoclonal antibody treatment for COVID-19 received full approval to treat patients with COVID-19…

4 years ago

First HER2 directed therapy to show a strong tumor response in this population Data from HER2 mutant cohort of pivotal…

Enfusion Files Registration Statement with SEC for Proposed Initial Public Offering

4 years ago

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion"), a leading provider of cloud-based investment management software and services,…

Metals Acquisition Corp. Announces the Separate Trading of its Shares of Class A Ordinary Shares and Redeemable Warrants Commencing September 20, 2021

4 years ago

FORT WORTH, Texas--(BUSINESS WIRE)--Metals Acquisition Corp. (NYSE: MTAL.U) (the �Company�) announced that, commencing September 20, 2021, holders of the units…

4 years ago

First ENHERTU trial in Western patients with gastric cancer Efficacy and safety results consistent with pivotal DESTINY-Gastric01 trial; will support…

Show more Posts
Show previous Posts